Evaluation of long-term consumption of omeprazole disadvantages: a network analysis
Gastroenterology and Hepatology from Bed to Bench,
Aim: Evaluation of deregulated genes after long-term consuming of omeprazole via network analysis.
Background: Proton pump inhibitors (PPIs) are used to inhibit gastric high rate of acid secretion in patients. Omeprazole as a PPI is a common drug in this regard. Evaluation of long-term consumption of omeprazole is studied in the present study via its effects on the gene expression of “human coronary artery endothelial cells”.
Methods: Net effect of the presence of omeprazole on gene expression profiles of “human coronary artery endothelial cells” was evaluated through data from gene expression omnibus (GEO). Results of protein-protein interaction (PPI) network analysis were assessed via biological process examination to find the critical deregulated genes after long-term consumption of omeprazole.
Results: “Negative regulation of muscle cell apoptotic process”, “negative regulation of DNA binding”, “telencephalon cell migration”, “forebrain cell migration” “response to cadmium ion”, “cell-cell recognition”, “positive regulation of protein targeting to mitochondrion”, and “central nervous system neuron development” were the clusters of biological processes that were associated to the long -term presence of omeprazole. The final critical deregulated genes were JAK2, PTK2, and NRG1.
Conclusion: It can be concluded that cell cycle, proliferation, and apoptosis and several essential biological processes are affected and nervous system is a possible target related to the long-term consumption of omeprazole.
Keywords: Omeprazole, Long term consumption, Gene expression.
(Please cite as: Nikzamir AR, Rezaei-Tavirani M, Razzaghi MR, Rezaei Tavirani S, Hamzeloo-Moghadam M, Esmaeili S, et al. Evaluation of long-term consumption of omeprazole disadvantages: a network analysis. Gastroenterol Hepatol Bed Bench 2020;13(Suppl.1):S98-S105).
- Omeprazole; Long term consumption; Gene expression
How to Cite
Pavlopoulos GA, Wegener AL, Schneider R. A survey of visualization tools for biological network analysis. BioData Min 2008;1:12.
Su G, Morris JH, Demchak B, Bader GD. Biological network exploration with Cytoscape 3. Curr Protoc Bioinf 2014;47:8-13.
Koschützki D, Schreiber F. Centrality analysis methods for biological networks and their application to gene regulatory networks. Gene Regul Syst Bio 2008;2:193-201.
Shokrzadeh L, Baghaei K, Yamaoka Y, Dabiri H, Jafari F, Sahebekhtiari N, et al. Analysis of 3'-end variable region of the cagA gene in Helicobacter pylori isolated from Iranian population. J Gastroenterol Hepatol 2010;25:172-7.
Lee H, Mashour GA, Noh GJ, Kim S, Lee U. Reconfiguration of network hub structure after propofol-induced unconsciousness. Anesthesiology 2013;119.
Newman ME. A measure of betweenness centrality based on random walks. Soc Networks 2005;27:39-54.
Yu H, Kim PM, Sprecher E, Trifonov V, Gerstein M. The importance of bottlenecks in protein networks: correlation with gene essentiality and expression dynamics. PLoS Comput Biol 2007;3.
Safari-Alighiarloo N, Rezaei-Tavirani M, Taghizadeh M, Tabatabaei SM, Namaki S. Network-based analysis of differentially expressed genes in cerebrospinal fluid (CSF) and blood reveals new candidate genes for multiple sclerosis. PeerJ 2016;4:e2775.
Abbaszadeh HA, Peyvandi AA, Sadeghi Y, Safaei A, Zamanian-Azodi M, Khoramgah MS, et al. Er: YAG laser and cyclosporin A effect on cell cycle regulation of human gingival fibroblast cells. J Lasers Med Sci 2017;8:143.
Rezaei-Tavirani M, Rezaei-Tavirani S, Mansouri V, Rostami-Nejad M, Rezaei-Tavirani M. Protein-protein interaction network analysis for a biomarker panel related to human esophageal adenocarcinoma. Asian Pacific J Cancer Prev 2017;18:3357.
Jafari M, Mirzaie M, Sadeghi M, Marashi SA, Rezaei-Tavirani M. Exploring biological processes involved in embryonic stem cell differentiation by analyzing proteomic data. Biochim Biophys Acta Proteins Proteom 2013;1834:1063-9.
Costarelli L, Giacconi R, Malavolta M, Basso A, Piacenza F, Provinciali M, et al. Different transcriptional profiling between senescent and non-senescent human coronary artery endothelial cells (HCAECs) by Omeprazole and Lansoprazole treatment. Biogerontology 2017;18:217-36.
Szklarczyk D, Morris JH, Cook H, Kuhn M, Wyder S, Simonovic M, ET AL. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res 2017;45:D362-68.
Mansouri V, Tavirani MR, Zadeh-Esmaeel MM, Rezaei-Tavirani S, Razzaghi M, Okhovatian F, et al. Analysis of Laser Therapy Effects on Squamous Cell Carcinoma Patients: A System Biology Study. J Lasers Med Sci 2019;10:1-6.
Mlecnik B, Galon J, Bindea G. Automated exploration of gene ontology term and pathway networks with ClueGO-REST. Bioinformatics 2019;35:3864-6.
Wang Y, Yu W, Shi C, Jiao W, Li J, Ge J, et al. Network Pharmacology of Yougui Pill Combined with Buzhong Yiqi Decoction for the Treatment of Sexual Dysfunction. Evid Based Complement Alternat Med 2019;2019: 1243743.
SH YYC, Hsuen-Wen C, Lin I, Li-Nien C, Min-Ju W, Yun-Ru L, et al. Long-term Proton Pump Inhibitor Administration Caused Physiological and Microbiota Changes in Rats. Sci Rep 2020;10.
Jiang K, Jiang X, Wen Y, Liao L, Liu Fb. Relationship between long‐term use of proton pump inhibitors and risk of gastric cancer: A systematic analysis. J Gastroenterol Hepatol 2019;34:1898-905.
Fan Z, Duan J, Wang L, Xiao S, Li L, Yan X, et al. PTK2 promotes cancer stem cell traits in hepatocellular carcinoma by activating Wnt/β-catenin signaling. Cancer Lett 2019;450:132-43.
Jafari F, Hamidian M, Rezadehbashi M, Doyle M, Salmanzadeh-Ahrabi S, Derakhshan F, et al. Prevalence and antimicrobial resistance of diarrheagenic Escherichia coli and Shigella species associated with acute diarrhea in Tehran, Iran. Can J Infect Dis Med Microbiol 2009;20:e56-62.
Novotny M, Klimova B, Valis M. PPI long term use: risk of neurological adverse events? Front Neurol 2019;9:1142.
Taghipour N, Aghdaei HA, Haghighi A, Mossafa N, Tabaei SJ, Rostami-Nejad M. Potential treatment of inflammatory bowel disease: a review of helminths therapy. Gastroenterol Hepatol Bed Bench 2014;7:9-16.
Morgan KJ, Gilliland DG. A role for JAK2 mutations in myeloproliferative diseases. Annu Rev Med 2008;59:213-22.
Garcia-Barcelo MM, Tang CSM, Ngan ESW, Lui VCH, Chen Y, So MT, et al. Genome-wide association study identifies NRG1 as a susceptibility locus for Hirschsprung's disease. Proc Natl Acad Sci U S A 2009;106:2694-9.
Goudarzi M, Goudarzi H, Alebouyeh M, Azimi Rad M, Shayegan Mehr FS, Zali MR, et al. Antimicrobial susceptibility of clostridium difficile clinical isolates in iran. Iran Red Crescent Med J 2013;15:704-11.
- Abstract Viewed: 0 times
- PDF Downloaded: 0 times